Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126448741 | 12644874 | 1 | I | 201606 | 20160802 | 20160811 | 20160811 | EXP | FR-JNJFOC-20160801125 | JANSSEN | 65.00 | YR | A | F | Y | 0.00000 | 20160811 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126448741 | 12644874 | 1 | SS | DUROGESIC | FENTANYL | 1 | Transdermal | N | 0 | MATRIX PATCH | |||||||||
| 126448741 | 12644874 | 2 | PS | DUROGESIC | FENTANYL | 1 | Transdermal | 50+12.5 UG/HR | N | 19813 | MATRIX PATCH | ||||||||
| 126448741 | 12644874 | 3 | SS | FLUOROURACILE ACCORD | FLUOROURACIL | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126448741 | 12644874 | 4 | SS | OXALIPLATINE HOSPIRA | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | U | 0 | UNSPECIFIED | |||||||||
| 126448741 | 12644874 | 5 | SS | IRINOTECAN ACCORD | IRINOTECAN | 1 | Intravenous (not otherwise specified) | U | 0 | UNSPECIFIED | |||||||||
| 126448741 | 12644874 | 6 | SS | ABSTRAL | FENTANYL CITRATE | 1 | Sublingual | 0 | TABLET | ||||||||||
| 126448741 | 12644874 | 7 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 | 1 | G | UNSPECIFIED | QID | |||||||
| 126448741 | 12644874 | 8 | C | SPASFON | PHLOROGLUCINOL | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126448741 | 12644874 | 1 | Pain |
| 126448741 | 12644874 | 2 | Pain |
| 126448741 | 12644874 | 3 | Pancreatic carcinoma metastatic |
| 126448741 | 12644874 | 4 | Pancreatic carcinoma metastatic |
| 126448741 | 12644874 | 5 | Pancreatic carcinoma metastatic |
| 126448741 | 12644874 | 6 | Product used for unknown indication |
| 126448741 | 12644874 | 7 | Product used for unknown indication |
| 126448741 | 12644874 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126448741 | 12644874 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126448741 | 12644874 | Agranulocytosis | |
| 126448741 | 12644874 | Blood phosphorus decreased | |
| 126448741 | 12644874 | Diarrhoea | |
| 126448741 | 12644874 | Hypokalaemia | |
| 126448741 | 12644874 | Thrombocytopenia | |
| 126448741 | 12644874 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126448741 | 12644874 | 1 | 201605 | 0 | ||
| 126448741 | 12644874 | 2 | 20160613 | 0 | ||
| 126448741 | 12644874 | 3 | 20160613 | 20160613 | 0 | |
| 126448741 | 12644874 | 4 | 20160613 | 20160613 | 0 | |
| 126448741 | 12644874 | 5 | 20160613 | 20160613 | 0 | |
| 126448741 | 12644874 | 6 | 201605 | 0 | ||
| 126448741 | 12644874 | 7 | 20160613 | 0 |